Invivyd

Invivyd

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$0.95
Previous Close
$0.93
Day Range
$0.92-$0.95
52W Range
$0.48-$3.06
Market Cap
$269.3M
Shares Short
30M

Financials

See more
Revenue (12 Mos)
$55.8M
Revenue Growth (YoY)
21.6%
Gross Profit (12 Mos)
$51.9M
Diluted EPS
-$0.29

News

See more

Yahoo Finance • 15 days ago

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration

Yahoo Finance • last month

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

Yahoo Finance • 2 months ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance • 3 months ago

Invivyd rises after update from late-stage trial for COVID therapy

About

CFO
Mr. William E. Duke Jr., M.B.A.
Address
209 Church Street, New Haven, CT, United States, 06510
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
122